Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Magainin awarded SBIR grant for squalamine

March 1, 1999

Matrix begins treating patients in phase II study of FMdC

Feb. 26, 1999

Magainin reports interim results of squalamine trial

Feb. 26, 1999

FDA grants priority review status to U.S. Bioscience's sNDA for Ethyol

Feb. 25, 1999

Ilex Oncology initiates phase III trial of DFMO

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

NCI to conduct phase III trial of pure shark cartilage

Feb. 24, 1999

Orphan Medical launches improved form of busulfan in U.S.

Feb. 24, 1999

U.S. patent extends coverage for Immune Response's TCR vaccine technology

Feb. 24, 1999

Immunomedics and NCI to study new class of anticancer agents

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.